Skip to main content

Table 3 Lymphoepithelioma-like carcinoma of the urinary bladder: histological subgroups according to the classification of Amin et al .

From: Lymphoepithelioma-like carcinoma of the urinary bladder: a case report and review of the literature

Features

Group 1- Pure

Group 2- Predominant

Group 3- Focal

Number of patients

39 (49%)

26 (34%)

13 (17%)

  Male

21

14

11

  Female

2

12

2

  NA

16

-

-

Age

   

  Mean

67.8

72.7

71.6

  Range

52-81

55-90

58-84

Stage

   

  T1

7 (18%)

1 (3%)

2 (15%)

  T2

21 (54%)

16 (62%)

7 (54%)

  T3

8 (22%)

9 (35%)

4 (31%)

  T4

2 (6%)

-

-

Primary treatment

   

  TURBT

23 (59%)

14 (54%)

7 (54%)

  Partial cystectomy

2 (5%)

2 (8%)

-

  Radical cystectomy

14 (36%)

10 (38%)

6 (46%)

Adjuvant treatment

   

  Systemic chemotherapy

15 (38%)

3 (12%)

1 (8%)

  Radiotherapy

6 (16%)

5 (19%)

3 (23%)

  Chemoradiotherapy

2 (5%)

1 (4%)

1 (8%)

  Intravesical chemotherapy

3 (8%)

-

-

  Not performed

13 (33%)

17 (65%)

8 (61%)

Follow-up

   

  Mean

35.2

30.1

30.6

  Range

2-216

2-104

0-84

Outcome

   

  Not evidence of disease (NED)

31 (81%)

20 (84%)

1 (8%)

  Died of disease (DOD)

1 (3%)

1 (4%)

11 (84%)

  Died without disease (DWD)

5 (13%)

2 (8%)

1 (8%)

  Alive with metastases (AWM)

1 (3%)

1 (4%)

-

Cause-specific survival rate

97%

95%

15%

  1. GH Gross hematuria, TURBT Transurethral resection of the bladder tumor.